RoseRx

As treatment sequencing becomes more complex and drug options more varied, effective patient engagement is more crucial than ever. The patient healthcare journey starts online, and the RoseRx platform is designed to optimise this experience. Our platform offers both consumers and healthcare providers a personalised experience, answering questions and guiding them through their healthcare journey. Additionally, our real time attribute feature uses detailed analytics to connect online and offline activity, maximising the impact of digital spending. Learn more about how we can help @ www.roserx.health #HealthcareInnovation #PatientCare #RoseRx #MedicalTechnology #DigitalHealth

Just announced in PharmaInFocus, RoseRx is proud to be partnering with Australian biotech Minomic International Ltd to bring end-to-end, healthcare-as-a-service — including product screeners, personalised education, urologist finders, and human powered care navigators to help patients navigate to the right testing protocol for identifying aggressive prostate cancer risk. This collaboration is set to accelerate Minomic International Ltd's commercial success in the USA. Similar to the recently launched PfizerForAll, direct-to-consumer healthcare models are gaining traction globally, and RoseRx is excited to be bringing the same direct-to-consumer capabilities to Australian biotechs like Minomic International Ltd. Minomic’s MiCheck® Prostate test is a non-invasive diagnostic test that helps identify aggressive prostate cancer, potentially reducing unnecessary biopsies and improving clinical outcomes. And we’re proud to work with Minomic International Ltd to connect qualified patients with this game-changer in health diagnostics. If you’d like to learn more about how the RoseRx platform can help biotechs accelerate their commercialisation efforts. Book a demo today: https://lnkd.in/gEXedVXt

💡Did you know that the average doctor in a U.S. emergency department clicks 4,000 times per day within electronic health record systems? This eye opening insight was shared by Chase Feiger, M.D. during our recent discussion on Redefining Pharma-Doctor Engagement. As pharmaceutical marketers - when it comes to digital communications with HCPs, it's crucial to deliver information in a streamlined and concise manner that respects their time and energy. At RoseRx, our platform helps life science companies create tailored, personalised digital engagement solutions for the specific needs of HCPs. 💬Talk to us today to learn more: https://lnkd.in/eeQdjKtR   #Pharma #Healthcare #DigitalEngagement #PharmaMarketing #RoseRx

In our recent fireside chat, Chase Feiger, M.D. flagged the importance of personalisation in tailoring your engagement to the needs of HCPs. Citing the example of Netflix, he noted: 💡The needs of different doctors and their experiences and backgrounds are going to influence how your engagement is perceived, some doctors need more detail to bring them along the education journey, but others may view it as time wasting their time. 💡Combining digital and in person approaches can help pharma find the right balance to provide information in a tailored and personalised manner.  At RoseRx, our platform helps life science companies create tailored, personalised digital engagement solutions that meet the needs of both HCPs and patients. 💬 Talk to us today to learn more: https://lnkd.in/eeQdjKtR #Pharma #Healthcare #DigitalHealth #RoseRx #MedicalEducation

In our recent fireside chat, Dr Joseph Santos and Marcel Knesl shared valuable insights on the evolving landscape of pharma-doctor interactions. In this clip, their key takeaways included: 💡 There's a growing preference towards digital engagement and updates, especially among younger doctors and registrars. 💡 Clinical trial results are often reaching doctors as soon as they are released at conferences via social media, or email, and long before meetings with pharmaceutical reps, highlighting the need for tailored and timely digital communication. At RoseRx, our platform helps life science companies manage this shift by providing integrated digital engagement solutions that meet the needs of both doctors and patients. Talk to us today to learn more: https://lnkd.in/eeQdjKtR #Pharma #Healthcare #DigitalEngagement #PharmaMarketing #RoseRx

What an incredible discussion last night during our fireside chat with our panel of doctors Chase Feiger, M.D. Dr Joseph Santos and Marcel Knesl in discussion with RoseRx Founder and CEO Romain Bonjean. Our panel shared valuable insights for any life science company who wants improved outcomes from their engagement initiatives with doctors, including: 💡Doctors have unprecedented digital access to evidence-based information - and are going direct 💡Doctors are increasingly connecting ‘peer-to-peer’ with trusted domain experts tor information - relationships are key 💡The next generation of doctors are not as comfortable with face-to-face engagement methods - so digital engagement is essential. A big thank you to our discussion panel for sharing their insights, and everyone who joined the discussion, both in-person and online. Plus, we’d like to thank our event co-hosts Paper + Spark, and in particular, Chief Spark, Zeina Khodr who shared key findings from their latest research. If you would like to learn more about how RoseRx or Paper+Spark can help life science companies achieve positive treatment outcomes - sooner - Reach out to schedule a confidential discussion - today. RoseRx: Complete this form: https://lnkd.in/gEXedVXt Or email: [email protected] Paper + Spark: Email: [email protected] #Pharma #Healthcare #DigitalMarketing #HealthcareConsumerisation #Webinar #Event

Digital-first doctors often learn about new research findings as soon as it breaks online. So Marcel Knesl believes the role for pharma reps in sharing this information has changed, and they can instead add value by focusing on other areas. #Pharma #Healthcare #DigitalMarketing #HealthcareConsumerisation #Webinar #Event

When he researches new treatment options, Dr Joseph Santos explains why he prefers to dive into the research first, by looking at what has been presented at recent conferences, before questions to a pharmaceutical rep. #Pharma #Healthcare #DigitalMarketing #HealthcareConsumerisation #Webinar #Event

RoseRx’s Founder and CEO Romain Bonjean asks our panel members Chase Feiger, M.D. Dr Joseph Santos & Marcel Knesl to share their thoughts on the current state of doctor-pharma engagement - and what an ideal interaction with a rep looks like. #Pharma #Healthcare #DigitalMarketing #HealthcareConsumerisation #Webinar #Event

Zeina Khodr, Chief Spark and Founder of Paper + Spark gets 'Redefining Pharma-Doctor Engagement: How Pharma Can Help The Modern Clinician' underway tonight.